---
title: "Esprit BTK: Drug-eluting resorbable scaffold poised as first-line therapy for below-the-knee CLTI"
date: "2025-08-26T11:42:32.000Z"
publishedDate: "26 août 2025"
summary: "This advertorial, sponsored by Abbott, is only available to readers in the USA. The post Esprit BTK: Drug-eluting resorbable scaffold poised as first-line therapy for below-the-knee CLTI appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/esprit-btk-drug-eluting-resorbable-scaffold-poised-as-first-line-therapy-for-below-the-knee-clti/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-08-26-esprit-btk-drug-eluting-resorbable-scaffold-poised-as-first-line-therapy-for-below-the-knee-clti"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/08/Esprit-BTK-135NoType-hi-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/esprit-btk-drug-eluting-resorbable-scaffold-poised-as-first-line-therapy-for-below-the-knee-clti/"
---

![Esprit BTK: Drug-eluting resorbable scaffold poised as first-line therapy for below-the-knee CLTI](https://vascularnews.com/wp-content/uploads/sites/7/2025/08/Esprit-BTK-135NoType-hi-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/esprit-btk-drug-eluting-resorbable-scaffold-poised-as-first-line-therapy-for-below-the-knee-clti/*

## L’essentiel

This advertorial, sponsored by Abbott, is only available to readers in the USA. The post Esprit BTK: Drug-eluting resorbable scaffold poised as first-line therapy for below-the-knee CLTI appeared first on Vascular News .

## Lien source

https://vascularnews.com/esprit-btk-drug-eluting-resorbable-scaffold-poised-as-first-line-therapy-for-below-the-knee-clti/
